A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis

Molecular Cell

Volumn 5, Issue 4, 2000, Pages 717-727

  Glickman, Michael S ^a   Cox, Jeffery S ^a   Jacobs Jr , William R ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CYCLOPROPANE DERIVATIVE; GLYCOLIPID; MYCOLIC ACID; SYNTHETASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIAL VIRULENCE; BACTERIUM MUTANT; CHRONIC DISEASE; ENZYME SYNTHESIS; MORPHOLOGY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PERSISTENT INFECTION; TUBERCULOSIS;

ANIMALIA; BACTERIA (MICROORGANISMS); MYCOBACTERIUM; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM TUBERCULOSIS;

EID: 0033634971     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(00)80250-6     Document Type: Article

References (52)

1. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: Five years of follow-up in the IUAT trial. International Union Against Tuberculosis Committee on Prophylaxis
2. Morphologic variation in pneumococcus
3. Allelic exchange in Mycobacterium tuberculosis with long linear recombination substrates
4. Conditionally replicating mycobacteriophages: A system for transposon delivery to Mycobacterium tuberculosis
5. Mycolic acids: Structure, biosynthesis and physiological functions
6. Induction of pulmonary granulomas, macrophage procoagulant activity, and tumor necrosis factor-alpha by trehalose glycolipids
7. Comparative genomics of BCG vaccines by whole-genome DNA microarray
8. Attenuation of virulence by disruption of the Mycobacterium tuberculosis erp gene
9. Preparation of cell-wall fractions from Mycobacteria
10. Studies on the virulence of tubercle bacilli. Isolation and biological properties of a constituent of virulent organisms
11. The envelope of mycobacteria
12. Conditionally replicating luciferase reporter phages: Improved sensitivity for rapid detection and assessment of drug susceptibility of Mycobacterium tuberculosis
13. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages
14. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
15. Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice
16. The envelope layers of mycobacteria with reference to their pathogenicity
17. Cord-forming property, lethality and pathogenicity of Mycobacteria
18. Mycobacterium bovis BCG genes involved in the biosynthesis of cyclopropyl keto- and hydroxy-mycolic acids
19. Mutations in the cmaB gene are responsible for the absence of methoxymycolic acid in Mycobacterium bovis BCG Pasteur
20. Virulence ranking of some Mycobacterium tuberculosis and Mycobacterium bovis strains according to their ability to multiply in the lungs, induce lung pathology, and cause mortality in mice
21. Global burden of tuberculosis - estimated incidence, prevalence, and mortality by country
22. The biosynthesis of cyclopropanated mycolic acids in Mycobacterium tuberculosis. Identification and functional analysis of CMAS-2
23. Cyclopropane ring formation in membrane lipids of bacteria
24. Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides
25. Mechanisms of lipid antigen presentation by CD1
26. Introduction of foreign DNA into mycobacteria using a shuttle phasmid
27. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides
28. Isoniazid-related hepatitis: A U.S. Public Health Service cooperative surveillance study
29. Expression of katG in Mycobacterium tuberculosis is associated with its growth and persistence in mice and guinea pigs
30. Direct cord reading medium for isolation of mycobacteria
31. Direct cord reading agar in routine mycobacteriology
32. Virulence and morphological characteristics of mammalian tubercle bacilli
33. Lipids: Complex lipids, their chemistry, biosynthesis and roles
34. Mycolic acid patterns of four vaccine strains of Mycobacterium bovis BCG
35. Mycolic acid patterns of representatives of Mycobacterium bovis BCG
36. Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells
37. Essential structure of cord factor analogues for TNF-priming, tumor-regressing and granuloma-forming activity in mice
38. Growth rate of mycobacteria in mice as an unreliable indicator of mycobacterial virulence
39. Fatty acids
40. A comparison of the construction of unmarked deletion mutations in Mycobacterium smegmatis, M. bovis bacille calmette-guerin (BCG), and M. tuberculosis H37Rv by allelic exchange
41. Efficient allelic exchange and transposon mutagenesis in Mycobacterium tuberculosis
42. Immunopathology of BCG infection in genetically resistant and susceptible mouse strains
43. Differential characteristics in vitro and in vivo of several substrains of BCG: Multiplication and survival in vivo
44. Tumor necrosis factor (cachectin) mediates induction of cachexia by cord factor from mycobacteria
45. Opacity genes in Neisseria gonorrhoeae: Control of phase and antigenic variation
46. Separation of the mixture of trehalose 6,6'-dimycolates comprising the mycobacterial glycolipid fraction, 'P3'
47. The growth phase-dependent synthesis of cyclopropane fatty acids in Escherihia coli is the result of an RpoS(KatF)-dependent promoter plus enzyme instability
48. Effect of inhA and katG on isoniazid resistance and virulence of Mycobacterium bovis
49. A common mechanism for the biosynthesis of methoxy and cyclopropyl mycolic acids in Mycobacterium tuberculosis
50. Identification of a gene involved in the biosynthesis of cyclopropanated mycolic acids in Mycobacterium tuberculosis
51. The effect of oxygenated mycolic acid composition on cell wall function and macrophage growth in Mycobacterium tuberculosis